Published online Nov 12, 2014. doi: 10.5318/wjo.v4.i4.113
Revised: July 5, 2014
Accepted: September 4, 2014
Published online: November 12, 2014
Core tip: (1) New diagnostic tools and therapies may improve the prognosis of patients with chronic or recurrent central serous chorioretinopathy; (2) Changes in fundus autoflouresence images help differentiate an active disease from an inactive state; (3) Multifocal electroretinography and macular microperimetry may serve as follow up tools due to their ability to measure macular visual function; (4) Focal argon laser photocoagulation shortens disease duration but does not affect final prognosis; (5) Reduced-fluence photodynamic therapy improves visual acuity and resolves serous detachments; and (6) The role of anti-vascular endothelial growth factor agents, micropulse diode laser, corticosteroid antagonists, aspirin, anti-viral or Helicobacter pylori treatment is still being investigated.